Utilize este identificador para referenciar este registo: http://hdl.handle.net/10451/47020
Título: Performance of referral strategies for spondyloarthritis : a population-based nationwide study
Autor: Sepriano, Alexandre Rocha
Ramiro, Sofia
Araújo, Filipe C
Machado, Pedro M
Rodrigues, Ana Maria
Gouveia, Nélia
Eusébio, Mónica
Canhao, Helena
Branco, Jaime
Palavras-chave: Spondyloarthritis
Referral strategies
Early diagnosis
Data: 2019
Editora: Oxford University Press
Citação: Rheumatology (Oxford). 2019 Jun 1;58(6):1086-1094
Resumo: Objectives: To evaluate the performance of the referral strategy (RS) for SpA of a nationwide epidemiological study (EpiReumaPt), as compared with previously proposed RSs. Methods: EpiReumaPt was a three-stage national epidemiologic study. In phase one, 10 661 adult participants were randomly selected and screened for rheumatic and musculoskeletal diseases. In the second phase, positive screenings for ⩾1 rheumatic and musculoskeletal disease plus 20% negative screenings were assessed by a rheumatologist. Finally, three rheumatologists revised all the information and defined the final diagnosis. All participants from phase two were included. Thirteen RS were tested against the SpA diagnosis using several metrics, including sensitivity, specificity, the post-test probability of SpA given a positive RS (positive predictive value) and given a negative RS (1 – negative predictive value). Results: From the total 3877 participants, 92 received a SpA diagnosis [weighted national prevalence: 1.6% (95% confidence interval: 1.2, 2.1)]. Modified versions of the Assessment of SpondyloArthritis international Society-RS and EpiReumaPt-RS were the most sensitive (85% and 72%, respectively) and yielded the lowest post-test probabilities of SpA if negative (0.6% and 0.7%, respectively). Considering the national prevalence (pre-test probability) of SpA (1.6%), a negative screening by these two RSs decreased the probability of SpA substantially (Assessment of SpondyloArthritis international Society: −63%; EpiReumaPt: −56%). Other RSs performed less well in reducing disease probability (range: −6.3%; −37.5%). Overall, the probability of SpA given a positive RS was small (positive predictive value range: 2.2%; 7.6%) and the EpiReumaPt RS yielded the best balance between sensitivity and positive predictive value. Conclusion: The proposed EpiReumaPt RS performed the best as a screening tool for SpA in patients from the general population when laboratory and imaging data were not available.
Descrição: Copyright © 2021 Oxford University Press
Peer review: yes
URI: http://hdl.handle.net/10451/47020
DOI: 10.1093/rheumatology/key436
ISSN: 1462-0324
Versão do Editor: https://academic.oup.com/rheumatology
Aparece nas colecções:FM - Artigos em Revistas Internacionais

Ficheiros deste registo:
Ficheiro Descrição TamanhoFormato 
Performance_referral.pdf338,15 kBAdobe PDFVer/Abrir    Acesso Restrito. Solicitar cópia ao autor!


FacebookTwitterDeliciousLinkedInDiggGoogle BookmarksMySpace
Formato BibTex MendeleyEndnote 

Todos os registos no repositório estão protegidos por leis de copyright, com todos os direitos reservados.